SCHEMBL4075982

SCHEMBL4075982

Cc1ccccc1C1OC=C(C(=O)O)O1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.37
ALDH1A1 P00352 4/20 0.34
HTT P42858 3/20 0.34
MAPT P10636 2/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4E B2RXH2 3/20 0.33
HPGD P15428 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MYC P01106 1/20 0.33
MAOB P27338 1/20 0.33
TP53 P04637 1/20 0.33
NOTUM Q6P988 1/20 0.33
HSD17B10 Q99714 2/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
NR1H4 Q96RI1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5391673 0.82 CA12 (0.37) ALDH1A1GAAKDM4EHPGDCA12
SCHEMBL1446431 0.77 MAPT (0.39) ALDH1A1MAPTTSHRKDM4EHPGD
SCHEMBL687579 0.67 HTR2C (0.41) ALDH1A1TSHRCA1CA2CA9
SCHEMBL9849476 0.66 TSHR (0.45) ALDH1A1TSHRCA1CA2CA9
SCHEMBL29655183 0.63 TAAR1 (0.41) ALDH1A1MAPTTSHRHPGDL3MBTL1
SCHEMBL230546 0.63 CTRB1 (0.36)
SCHEMBL14012479 0.61 HTR2C (0.40) ALDH1A1TSHRNPSR1CA1CA2
SCHEMBL6590588 0.61 HTR2C (0.44) ALDH1A1TSHRMAOBHTR2AHTR2C
SCHEMBL6309846 0.61 HTR2C (0.41) ALDH1A1MAPTKDM4EHPGDL3MBTL1
SCHEMBL11318483 0.61 PBRM1 (0.39) ALDH1A1GAANPSR1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090312308-A1 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG SIGNALING PATHWAY MODULATORS IRM LLC (BM) 2009-12-17 US claimed
EP-2044065-A2 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS IRM, LLC (BM) 2009-04-08 EP claimed
WO-2008014291-A2 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG SIGNALING PATHWAY MODULATORS IRM LLC (BM) 2008-01-31 WO claimed
US-20090312308-A1 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG SIGNALING PATHWAY MODULATORS IRM LLC (BM) 2009-12-17 US disclosed
EP-2044065-A2 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG PATHWAY MODULATORS IRM, LLC (BM) 2009-04-08 EP disclosed
WO-2008014291-A2 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG SIGNALING PATHWAY MODULATORS IRM LLC (BM) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312308-A1 COMPOUNDS AND COMPOSITIONS AS HEDGEHOG SIGNALING PATHWAY MODULATORS GLI1, SHH, SMO HDAC4 1042/4885ALDH1A1 1979/4885HTT 1825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.